Cumulative dosages of chemotherapy and radiotherapy exposure, and risk of secondary malignancies after allogeneic hematopoietic stem cell transplantation

Ziegler Anke Katrin; Abend Michael; Port Matthias; Dammann Elke; Homeyer Rieke-Sophie; Eder Matthias; Ganser Arnold; Schrem Harald; Koenecke Christian

首页> 外文期刊>Bone marrow transplantation >Cumulative dosages of chemotherapy and radiotherapy exposure, and risk of secondary malignancies after allogeneic hematopoietic stem cell transplantation

【24h】

Cumulative dosages of chemotherapy and radiotherapy exposure, and risk of secondary malignancies after allogeneic hematopoietic stem cell transplantation

机译：化疗累积剂量和放射疗法暴露，同种异体造血干细胞移植后继发性恶性肿瘤风险

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Bone marrow transplantation》 |2019年第4期|共6页
作者
Ziegler Anke Katrin; Abend Michael; Port Matthias; Dammann Elke; Homeyer Rieke-Sophie; Eder Matthias; Ganser Arnold; Schrem Harald; Koenecke Christian;
展开▼
作者单位

Hannover Med Sch Hematol Hemostasis Oncol &

Stem Cell Transplantat Hannover Germany;

Bundeswehr Inst Radiobiol Munich Germany;

Bundeswehr Inst Radiobiol Munich Germany;

Hannover Med Sch Hematol Hemostasis Oncol &

Stem Cell Transplantat Hannover Germany;

Hannover Med Sch Integrated Res &

Treatment Ctr Transplantat IFB T Core Facil Qual Management;

Hannover Med Sch Hematol Hemostasis Oncol &

Stem Cell Transplantat Hannover Germany;

Hannover Med Sch Hematol Hemostasis Oncol &

Stem Cell Transplantat Hannover Germany;

Hannover Med Sch Integrated Res &

Treatment Ctr Transplantat IFB T Core Facil Qual Management;

Hannover Med Sch Hematol Hemostasis Oncol &

Stem Cell Transplantat Hannover Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词
入库时间 2022-08-19 23:02:53

相似文献

外文文献
中文文献
专利

1. Cumulative dosages of chemotherapy and radiotherapy exposure, and risk of secondary malignancies after allogeneic hematopoietic stem cell transplantation [J] . Ziegler Anke Katrin, Abend Michael, Port Matthias, Bone marrow transplantation . 2019,第4期

机译：化疗累积剂量和放射疗法暴露，同种异体造血干细胞移植后继发性恶性肿瘤风险
2. A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies [J] . Barbara Spitzer, Ann A. Jakubowski, Esperanza B. Papadopoulos, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2017,第12期

机译：仅由Busulfan，Melphalan和Fludarabine的化疗方案，以及兔Antithymocyte球蛋白，然后是同种异体T细胞耗尽的造血干细胞移植治疗骨髓性恶性肿瘤
3. NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies. [J] . Kroger N, Bacher U, Bader P, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2010,第10期

机译：NCI第一次国际研讨会，关于异基因造血干细胞移植后复发的生物学，预防和治疗：来自疾病特异性方法和策略委员会的报告，用于监测异基因干细胞移植后的复发。第二部分：慢性白血病，骨髓增生性肿瘤和淋巴样恶性肿瘤。
4. Intravenous Busulfan Reduces Toxicity Associated with Myeloablative Allogeneic Hematopoietic Transplantation in Patients with Myeloid Malignancies [C] . A. Shimoni, B. Bxelorai, I. Hardan, European Haematology Association . 2002

机译：静脉内的伯鲁兰减少骨髓恶性肿瘤患者患有髓鞘异产造血移植的毒性
5. Pre-Transplant Risk Factors Associated With Worse Outcomes in Adolescents and Young Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [D] . Friend, Brian. 2018

机译：与经历同种异体造血干细胞移植的青少年和青少年较差的预移植危险因素
6. A Chemotherapy-only Regimen of Busulfan Melphalan and Fludarabine and Rabbit ATG followed by Allogeneic T-cell Depleted Hematopoietic Stem Cell Transplants for the Treatment of Myeloid Malignancies [O] . Barbara Spitzer, Ann A. Jakubowski, Esperanza B. Papadopoulos, -1

机译：白消安美法仑和氟达拉滨和兔ATG的仅化学疗法方案然后用同种异体T细胞贫血造血干细胞移植治疗骨髓恶性肿瘤。
7. MT4 MIXED TREATMENT COMPARISON (MTC) OF ANTIFUNGAL DRUGS FOR PROPHYLAXIS TREATMENT AGAINST INVASIVE FUNGAL INFECTIONS (IFIS) IN PATIENTS RECEIVING CHEMOTHERAPY FOR HEMATOLOGICAL MALIGNANCIES OR ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION [O] . Pechlivanoglou P, Le HH, De Vries R, 2010

机译：MT4接受药物治疗血液学恶性肿瘤或异基因造血干细胞移植的感染性真菌感染（IFIS）的预防性真菌感染混合真菌药物（MTC）的比较治疗

Cumulative dosages of chemotherapy and radiotherapy exposure, and risk of secondary malignancies after allogeneic hematopoietic stem cell transplantation

著录项

相似文献

相关主题

期刊订阅